|
gptkbp:instanceOf
|
patent family
|
|
gptkbp:covers
|
pharmaceutical compositions
|
|
gptkbp:hasAssignee
|
gptkb:XYZ_Corporation
|
|
gptkbp:hasCitations
|
10
|
|
gptkbp:hasClaim
|
20
|
|
gptkbp:hasCollaboratedWith
|
gptkb:University_of_Science
|
|
gptkbp:hasDescription
|
A compound for treating diseases.
|
|
gptkbp:hasFieldOfUse
|
medicinal chemistry
|
|
gptkbp:hasFilingDate
|
2004-03-31
|
|
gptkbp:hasFilm
|
nausea
|
|
gptkbp:hasFunding
|
gptkb:National_Institutes_of_Health
|
|
gptkbp:hasInternationalClassification
|
A61K
|
|
gptkbp:hasInventor
|
gptkb:John_Doe
|
|
gptkbp:hasLegalStatus
|
granted
|
|
gptkbp:hasMerchandise
|
inhibitor
|
|
gptkbp:hasPerformedAt
|
500 mg
|
|
gptkbp:hasPriorityDate
|
2004-03-31
2024-03-31
|
|
gptkbp:hasPrograms
|
well-studied
|
|
gptkbp:hasPublications
|
2004-09-14
|
|
gptkbp:hasRelatedPatent
|
gptkb:US_7,123,456
|
|
gptkbp:hasResearchInterest
|
Journal of Medicinal Chemistry
|
|
gptkbp:hasTechnicalField
|
organic chemistry
|
|
gptkbp:hasTheme
|
gptkb:US_6,789,917
|
|
gptkbp:hasTransportation
|
tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,917 C9 family
|
|
gptkbp:isAssignedTo
|
gptkb:XYZ_Corporation
|
|
gptkbp:isAttendedBy
|
oral route
|
|
gptkbp:isCitedBy
|
5
|
|
gptkbp:isCompatibleWith
|
yes
|
|
gptkbp:isEngagedIn
|
Phase II
|
|
gptkbp:isEvaluatedBy
|
safety
efficacy
|
|
gptkbp:isFiledIn
|
gptkb:United_States
|
|
gptkbp:isFiledUnder
|
US_patent_law
|
|
gptkbp:isFoundIn
|
multiple jurisdictions
|
|
gptkbp:isIncorporatedIn
|
yes
|
|
gptkbp:isMarketedAs
|
C9_Drug
|
|
gptkbp:isPartOf
|
therapeutic regimen
clinical research.
drug development pipeline
pharmaceutical patent portfolio
C9 patent family
therapeutic area
|
|
gptkbp:isPublishedIn
|
USPTO database
|
|
gptkbp:isRelatedTo
|
C9H13NO2
C9 compound
C9H13N
|
|
gptkbp:isSupportedBy
|
grants
|
|
gptkbp:isTargetedAt
|
specific patient population
specific receptors
|
|
gptkbp:isUsedFor
|
treatment of cancer
|
|
gptkbp:isUtilizedIn
|
clinical trials
|
|
gptkbp:isVisitedBy
|
gptkb:ABC_Research_Lab
oncology
|
|
gptkbp:market
|
FDA_approved
|
|
gptkbp:notableArtists
|
yes
|
|
gptkbp:searchAndRescueMissions
|
yes
|